Friday
8:15 – 9:15 Dr. Anderson Assessment of the cancer patient across the spectrum – Part-1
1. Standard tumor markers were touched on but not discussed in detail:
2. Non-specific markers like AlkPhos, CRP, LDH etc. are best used:
3. Two nutrient markers that can rise with cancer advancement mentioned were:
9:15 – 10:15 Dr. Tims Assessment of the cancer patient across the spectrum – Part-2
1. The idea of a “Liquid Biopsy” was mentioned:
2. Circulating tumor cells are 100% sensitive and specific:
3. As discussed in this session, CTC’s are:
11:00 – 12:00 Dr. Price Nutrigenomic Analysis: Assessing Genetic Analysis in Complementary Cancer Care and Culinary Nutrition/Assessing Epigenetic Guidance in Culinary Nutrition and Supplementation
1. “Nutrigenomics” refers to:
2. Knowing a patient’s SNP profile can help with:
3. Nutrigenomics can be used to:
2:30 – 3:30 Dr. Anderson Metabolic complications in the Patient with Cancer
1. Lymphedema is a mentioned disease complication of cancer:
2. Marrow Suppression is a mentioned disease complication of cancer:
3. RDW can be used to assess:
4:45 – 5:15 Dr. Anderson Early assessment of cancer: What to watch for
1. “Red Flags” mentioned include:
2. The concept of “documenting and monitoring suspicions” was:
3. If you enter “Rule Out” in your chart ‘Plan’ you:
SATURDAY
8:30 – 9:30 Dr. Abrams Nutrition and Cancer Guidelines: Updated but are they Upgraded?
1. This presentation discussed the WCRF/AICR Guidelines:
2. Patient weight is not a part of this discussion:
3. This session promoted the idea of “only one diet for cancer”:
11:15 – 12:15 Dr. Anderson Diet through the Four Phases of Cancer
1. The four phases include:
2. This presentation focused on:
12:15 – 12:45 Dr. Price Implementing Food as Medicine – from Theory to Plate
1. The use of herbs – spices in diet was mentioned in this session:
2. This presentation promoted a high meat intake for cancer:
3. A potentially medicinal spice mentioned was turmeric:
2:30 – 3:15 Dr. Espinosa Prostate Cancer Part-1: Top therapeutics and recent updates
1. This session mentioned ____ as possible use in low risk PrCA:
2. In this session medicinal mushrooms for low risk PrCA were:
3. The overall idea presented was Low risk PrCA and Advanced PrCA are treated identically
4:30 – 5:30 Dr. Tims / DrH Breast cancer - Top therapeutics and recent updates
1. This session discussed “restoring metabolic flexibility”
2. This session discussed therapies with:
3. Lymph drainage and colon hydrotherapy were discussed:
SUNDAY
8:30 – 9:00 Dr. Espinosa Prostate Cancer Part-2: The “other” Prostate Cancer.
1. This session asserted:
2. Managing ADT side effects was discussed:
3. Diet in advanced PrCA was said to best include:
9:00 – 9:30 Dr. Anderson Prostate Cancer Part-3: Considerations in metastatic Prostate Cancer
1. This session made the point that advanced PrCA:
2. A case for infections as comorbid and aggravating factors was made:
3. In addition to the above, a case was made for assessing _____ in advanced PrCA:
11:15 – 12:15 Dr. Abrams Cannabis in Cancer Care
1. The only legitimate medical cannabinoid is d-9 THC
2. The following are researched medical cannabinoids:
3. Medical cannabinoids are:
2:15 – 3:15 Dr. Abrams Integrating Traditional Chinese Medicine into Holistic Cancer Care
1. Chinese Medicine is limited to acupuncture:
2. The following may be part of a Chinese Medicine intervention:
3. Regarding the use of herbs from a Chinese medicine perspective:
3:15 – 4:15 Dr. Anderson Cancer Therapeutics a discussion of “Starving Cancer” and “Repurposed Drugs” in Oncology.
2. An example of a repurposed drug for oncology is:
3. The point was made that repurposed drugs have a place but not at the exclusion of all the foundational therapies:
Leave A Comment